Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-99-001679
Filing Date
1999-02-26
Accepted
1999-02-26 00:00:00
Documents
5
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 DUSA PHARMACEUTICALS, INC. 10-K 200747
2 CERTIFICATE OF INCORPORATION EX-3.A 3977
3 AMENDED AND RESTATED LICENSE AGREEMENT EX-10.E 49114
4 PURCHASE AND SUPPLY AGREEMENT EX-10.I 62982
5 FINANCIAL DATA SCHEDULE EX-27 2441
  Complete submission text file 0000950123-99-001679.txt   321256
Mailing Address 181 UNIVERSITY AVE STE 1208 TORONTO ONTARIO M5H 3M7 CANADA A6
Business Address 181 UNIVERSITY AVE, STE 1208 TORONTO, ONTARIO, CANADA M5H 3M7 A6 4163635059
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19777 | Film No.: 99552255
SIC: 2834 Pharmaceutical Preparations